According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are $0.42 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-09-30 | $0.46 B | 23.14% |
2022-09-30 | $0.37 B | -14.44% |
2021-09-30 | $0.43 B | -9.74% |
2020-09-30 | $0.48 B | -0.75% |
2019-09-30 | $0.48 B | 18.25% |
2018-09-30 | $0.41 B | 26.82% |
2017-09-30 | $0.32 B | 16.13% |
2016-09-30 | $0.28 B | 14.33% |
2015-09-30 | $0.24 B | 58.29% |
2014-09-30 | $0.15 B | 32.86% |
2013-09-30 | $0.11 B | 124.25% |
2012-09-30 | $52.16 M | 99.89% |
2011-09-30 | $26.09 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 39,003.48% | ๐บ๐ธ USA |
Novartis NVS | $94.33 B | 21,914.99% | ๐จ๐ญ Switzerland |
AbbVie ABBV | $134.71 B | 31,337.88% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $22.73 B | 5,204.61% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 24,795.04% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.03 B | 23,011.14% | ๐บ๐ธ USA |